<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01263990</url>
  </required_header>
  <id_info>
    <org_study_id>VaSNex</org_study_id>
    <secondary_id>EA1/199/10</secondary_id>
    <nct_id>NCT01263990</nct_id>
  </id_info>
  <brief_title>Validation of Stroke Volume Measurement by a New Noninvasive Hemodynamic Monitoring System (NexFin)in Comparison to Different Invasive Procedures as Picco2, FloTrac and TEE</brief_title>
  <acronym>VaSNex</acronym>
  <official_title>Prospective, Monocentric Pilot Study for the Validation of Stroke Volume by Use of NexFin in Comparison to Different Hemodynamic Monitoring Procedures (Picco2, FloTrac and TEE)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charite University, Berlin, Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Charite University, Berlin, Germany</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Main hypothesis: there is no difference between stroke volume measurements recorded by a new
      noninvasive finger cuff system (NexFin) and invasive hemodynamic monitoring systems as
      Picco2-system, FloTrac and transesophageal echocardiography
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In high risc patients undergoing orthopedic surgery an extended cardiopulmonary observation
      improves patients safety and postoperative outcome. Therefore invasive procedures as
      Picco2-system, FloTrac and transesophageal echocardiography (tee) have the advantage to
      measure or calculate stroke volume. Disadvantage of this treatments is the need for a
      vascular access with all its complications.

      In this study the stroke volume measured by a new noninvasive finger cuff system (NexFin)
      should be validated in comparison to invasive hemodynamic monitoring systems as
      Picco2-system, FloTrac and tee.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">May 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>stroke volume</measure>
    <time_frame>preinduction, 3 and 15 minutes after induction, before and after a volume challenge, 30 minutes after induction, end of surgery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>mean arterial pressure</measure>
    <time_frame>preinduction, 3 and 15 minutes after induction, before and after volume challenge, 30 minutes after induction, end of surgery</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Stroke Volume</condition>
  <condition>Mean Arterial Pressure</condition>
  <arm_group>
    <arm_group_label>Nexfin</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Nexfin is used in all patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>NexFin</intervention_name>
    <description>noninvasive finger cuff system</description>
    <arm_group_label>Nexfin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing orthopedic surgery with need for invasive blood pressure
             measurements

          -  age ≥ 18 years

          -  signed informed consent

          -  no participation on another interventional study

        Exclusion Criteria:

          -  refusal of participation

          -  patients who are not able to sign informed consent

          -  atrial fibrillation with arrhythmia

          -  peripheral arterial disease &gt; Fontain IIa

          -  scleroderma

          -  presence of an arterio-venous shunt on upper limb

          -  contraindication for femoral arterial vascular access

          -  contraindication for transesophageal echocardiography

          -  stage III heart valve defects

          -  shunt heart defects

          -  solitary regional anaesthesia

          -  pregnant or breastfeeding women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Sander, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. of Anesthesiology Charité Universitaetsmedizin Berlin</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Claudia Spies, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Dept. of Anesthesiology Charité Universitaetsmedizin Berlin</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Anesthesiology and Intensive Care Medicine Campus Charité Mitte / Campus Virchow-Klinikum</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 14, 2010</study_first_submitted>
  <study_first_submitted_qc>December 20, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 21, 2010</study_first_posted>
  <last_update_submitted>August 8, 2013</last_update_submitted>
  <last_update_submitted_qc>August 8, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 12, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charite University, Berlin, Germany</investigator_affiliation>
    <investigator_full_name>Michael Sander</investigator_full_name>
    <investigator_title>Vice Chair</investigator_title>
  </responsible_party>
  <keyword>hemodynamic monitoring systems</keyword>
  <keyword>stroke volume</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

